aTyr Pharma, Inc. (ATYR) — Capital Reinvestment Ratio

Latest as of March 2020: 0.08x

aTyr Pharma, Inc. (ATYR) has a Capital Reinvestment Ratio of 0.08x as of March 2020, meaning it reinvests 0% of its operating cash flow ($2.06 Million) in capital expenditures ($166.00K). See aTyr Pharma, Inc. (ATYR) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

$2.06 Million
USD

Capital Expenditures

$166.00K
USD

Data as of

Mar 2020
Most recent filing

Annual Capital Reinvestment Ratio for aTyr Pharma, Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for aTyr Pharma, Inc. from None to None. For live market cap and broader valuation context, see aTyr Pharma, Inc. (ATYR) market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow